OrthoPediatrics, which sells orthopedic implants designed for children, announced terms for its IPO on Monday.
The Warsaw, IN-based company plans to raise $52 million by offering 4 million shares at a price range of $12 to $14. At the midpoint of the proposed range, OrthoPediatrics would command a market value of $157 million.
OrthoPediatrics was founded in 2007 and booked $41 million in sales for the 12 months ended June 30, 2017. It plans to list on the Nasdaq under the symbol KIDS. Piper Jaffray and Stifel are the joint bookrunners on the deal. It is expected to price during the week of October 9, 2017.
